Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Abbas, 2010, Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value, Blood, 116, 2122, 10.1182/blood-2009-11-250878 Abdel-Wahab, 2009, Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies, Blood, 114, 144, 10.1182/blood-2009-03-210039 Dang, 2009, Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, 462, 739, 10.1038/nature08617 Delhommeau, 2009, Mutation in TET2 in myeloid cancers, N. Engl. J. Med., 360, 2289, 10.1056/NEJMoa0810069 Fernandez, 2009, Anthracycline dose intensification in acute myeloid leukemia, N. Engl. J. Med., 361, 1249, 10.1056/NEJMoa0904544 Figueroa, 2009, Genome-wide determination of DNA methylation by Hpa II tiny fragment enrichment by ligation-mediated PCR (HELP) for the study of acute leukemias, Methods Mol. Biol., 538, 395, 10.1007/978-1-59745-418-6_20 Figueroa, 2010, DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, 17, 13, 10.1016/j.ccr.2009.11.020 Fujiwara, 2009, Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy, Mol. Cell, 36, 667, 10.1016/j.molcel.2009.11.001 Hartmann, 2009, Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas, Acta Neuropathol., 118, 469, 10.1007/s00401-009-0561-9 Ito, 2010, Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification, Nature, 466, 1129, 10.1038/nature09303 Khulan, 2006, Comparative isoschizomer profiling of cytosine methylation: the HELP assay, Genome Res., 16, 1046, 10.1101/gr.5273806 Langemeijer, 2009, Acquired mutations in TET2 are common in myelodysplastic syndromes, Nat. Genet., 41, 838, 10.1038/ng.391 Lugthart, 2010, Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1, Blood Marcucci, 2010, IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, J. Clin. Oncol., 28, 2348, 10.1200/JCO.2009.27.3730 Mardis, 2009, Recurring mutations found by sequencing an acute myeloid leukemia genome, N. Engl. J. Med., 361, 1058, 10.1056/NEJMoa0903840 Noushmehr, 2010, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 17, 510, 10.1016/j.ccr.2010.03.017 Parsons, 2008, An integrated genomic analysis of human glioblastoma multiforme, Science, 321, 1807, 10.1126/science.1164382 Paschka, 2010, IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication, J. Clin. Oncol., 28, 3636, 10.1200/JCO.2010.28.3762 Spensberger, 2008, A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a, FEBS Lett., 582, 2761, 10.1016/j.febslet.2008.06.056 Stopka, 2005, PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure, EMBO J., 24, 3712, 10.1038/sj.emboj.7600834 Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 Tefferi, 2010, IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis, Leukemia, 24, 1302, 10.1038/leu.2010.113 Tsukada, 2006, Histone demethylation by a family of JmjC domain-containing proteins, Nature, 439, 811, 10.1038/nature04433 van den Bent, 2010, IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group, Clin. Cancer Res., 16, 1597, 10.1158/1078-0432.CCR-09-2902 Wagner, 2010, Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor, J. Clin. Oncol., 28, 2356, 10.1200/JCO.2009.27.6899 Ward, 2010, The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate, Cancer Cell, 17, 225, 10.1016/j.ccr.2010.01.020 Wu, 2010, Active DNA demethylation: many roads lead to Rome, Nat. Rev. Mol. Cell Biol., 11, 607, 10.1038/nrm2950 Yamane, 2006, JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor, Cell, 125, 483, 10.1016/j.cell.2006.03.027 Yan, 2009, IDH1 and IDH2 mutations in gliomas, N. Engl. J. Med., 360, 765, 10.1056/NEJMoa0808710